Dermata Therapeutics, Inc. (DRMA)
0.8699
+0.01
(+1.16%)
USD |
NASDAQ |
Oct 20, 16:00
0.85
-0.02
(-2.29%)
After-Hours: 05:46
Dermata Therapeutics Price to Book Value : 1.003 for Oct. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 20, 2026 | 1.003 |
| October 19, 2026 | 0.9917 |
| October 16, 2026 | 0.9918 |
| October 15, 2026 | 1.049 |
| October 14, 2026 | 0.7649 |
| October 13, 2026 | 0.9917 |
| October 12, 2026 | 1.026 |
| October 09, 2026 | 1.176 |
| October 08, 2026 | 1.234 |
| October 07, 2026 | 1.292 |
| October 06, 2026 | 1.303 |
| October 05, 2026 | 1.280 |
| October 02, 2026 | 1.274 |
| October 01, 2026 | 1.280 |
| September 30, 2026 | 1.268 |
| September 29, 2026 | 1.303 |
| September 28, 2026 | 1.292 |
| September 25, 2026 | 1.315 |
| September 24, 2026 | 1.349 |
| September 23, 2026 | 1.292 |
| September 22, 2026 | 1.326 |
| September 21, 2026 | 1.326 |
| September 18, 2026 | 1.338 |
| September 17, 2026 | 1.338 |
| September 16, 2026 | 1.326 |
| Date | Value |
|---|---|
| September 15, 2026 | 1.303 |
| September 14, 2026 | 1.326 |
| September 11, 2026 | 1.372 |
| September 10, 2026 | 1.384 |
| September 09, 2026 | 1.395 |
| September 08, 2026 | 1.442 |
| September 04, 2026 | 1.395 |
| September 03, 2026 | 1.418 |
| September 02, 2026 | 1.476 |
| September 01, 2026 | 1.499 |
| August 31, 2026 | 1.488 |
| August 28, 2026 | 1.545 |
| August 27, 2026 | 1.684 |
| August 26, 2026 | 1.857 |
| August 25, 2026 | 1.984 |
| August 24, 2026 | 1.880 |
| August 21, 2026 | 1.638 |
| August 20, 2026 | 1.591 |
| August 19, 2026 | 1.695 |
| August 18, 2026 | 1.649 |
| August 17, 2026 | 1.684 |
| August 14, 2026 | 1.684 |
| August 13, 2026 | 1.811 |
| August 12, 2026 | 1.591 |
| August 11, 2026 | 1.246 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 1.993 |
| Perspective Therapeutics, Inc. | 0.8102 |
| MiMedx Group, Inc. | 2.854 |
| ABVC BioPharma, Inc. | 2.330 |
| Agilent Technologies, Inc. | 6.625 |
Price to Book Value Related Metrics
| Price | 0.8699 |
| Earnings Yield | -504.2% |
| Market Cap | 3.499M |